Advertisement

Upregulation of ID2 antagonizes arsenic trioxide-induced antitumor effects in cancer cells

Abstract

Aims and background. Arsenic trioxide (ATO) strongly induces apoptosis and differentiation in acute promyelocytic leukemia, and induces cell cycle arrest in most solid tumors. Although many signaling pathways are involved in its antitumor mechanism, a detailed investigation of the transforming growth factor beta-bone morphogenetic protein signaling pathway has not been performed.
Methods and study design. A microarray containing 113 genes associated with the pathway was used to screen important molecules that participate in the antitumor effects of ATO. The expression levels of the inhibitors of DNA binding-2 (ID2) in 4 different types of cancer cells were determined by quantitative reverse transcription PCR and Western blotting. Human esophageal squamous cell carcinoma cell line Eca109 and pancreatic carcinoma cell line BxPC3 cells were transfected with siRNAs targeting ID2 and scrambled control siRNA. Cell proliferation was evaluated by methyl thiazolyl tetrazolium assay.
Results. Eighteen upregulated and 12 downregulated genes were identified. After verification at the transcriptional and translational levels in 4 different cancer cells, ID2 was identified as an ATO antitumor-associated protein. In addition, specific silencing of ID2 could enhance ATO-induced cell proliferation inhibition in cancer cells.
Conclusions. A combination of ATO and ID2-targeted agents may have considerable therapeutic benefits in cancers.

Tumori 2014; 100(3): 352 - 357

Article Type: ORIGINAL RESEARCH ARTICLE

DOI:10.1700/1578.17226

Authors

Xueyan Zhang, Chengqian Lv, Bing Du, Xiao Ma, Jingming Guan, Shanling Gao, Xiaodong Li, Lei Zheng, Guang-Hua Lei

Article History

This article is available as full text PDF.

  • If you are a Subscriber, please log in now.

  • Article price: Eur 36,00
  • You will be granted access to the article for 72 hours and you will be able to download any format (PDF or ePUB). The article will be available in your login area under "My PayPerView". You will need to register a new account (unless you already own an account with this journal), and you will be guided through our online shop. Online purchases are paid by Credit Card through PayPal.
  • If you are not a Subscriber you may:
  • Subscribe to this journal
  • Unlimited access to all our archives, 24 hour a day, every day of the week.

Authors

  • Zhang, Xueyan [PubMed] [Google Scholar]
    Department of Gastroenterology, the Second Hospital Affiliated to Harbin Medical University, Harbin, China
  • Lv, Chengqian [PubMed] [Google Scholar]
    Department of Gastroenterology, the Second Hospital Affiliated to Harbin Medical University, Harbin, China
  • Du, Bing [PubMed] [Google Scholar]
    Department of Gastroenterology, the Second Hospital Affiliated to Harbin Medical University, Harbin, China
  • Ma, Xiao [PubMed] [Google Scholar]
    Department of Gastroenterology, the Second Hospital Affiliated to Harbin Medical University, Harbin, China
  • Guan, Jingming [PubMed] [Google Scholar]
    Department of Gastroenterology, the Second Hospital Affiliated to Harbin Medical University, Harbin, China
  • Gao, Shanling [PubMed] [Google Scholar]
    Department of Gastroenterology, the Second Hospital Affiliated to Harbin Medical University, Harbin, China
  • Li, Xiaodong [PubMed] [Google Scholar]
    Department of Gastroenterology, the Second Hospital Affiliated to Harbin Medical University, Harbin, China
  • Zheng, Lei [PubMed] [Google Scholar]
    Department of Gastroenterology, the Second Hospital Affiliated to Harbin Medical University, Harbin, China
  • Lei, Guang-Hua [PubMed] [Google Scholar]
    Department of Histology and Embryology, Harbin Medical University, Harbin, China

Article usage statistics

The blue line displays unique views in the time frame indicated.
The yellow line displays unique downloads.
Views and downloads are counted only once per session.

No supplementary material is available for this article.